Biotech IV Monitor

SWTX — SpringWorks Therapeutics Inc.

Acquired by Merck KGaA · July 2025
SpringWorks Therapeutics Inc. was acquired by Merck KGaA in July 2025. SWTX no longer trades, so its trials are no longer stock catalysts and are left off the trial calendar. The records below are kept for reference; the programs now belong to Merck KGaA, and their dates may not have been updated since.

Clinical trial readout dates for SpringWorks Therapeutics Inc., compiled from ClinicalTrials.gov, alongside the SEC filings where results are announced. The next expected readout is May 2027.

Next readoutMay 2027in ~6 months
Upcoming readouts1none in Phase 3

Upcoming readouts

Phase 2 Nirogacestat oral tablet
Desmoid Tumor; Aggressive Fibromatosis · NCT07170644
May 2027
Ongoing

Companies working on similar indications

Discussion

No messages yet. If you follow SWTX, you can start the conversation.
Contact — questions or corrections about SWTX: dukeupt@gmail.com